NNH — New Nordic Healthbrands AB Cashflow Statement
0.000.00%
- SEK87.97m
- SEK111.94m
- SEK550.31m
- 48
- 73
- 19
- 41
Annual cashflow statement for New Nordic Healthbrands AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 23.8 | 28.5 | -4.75 | -3.17 | -4.45 |
Depreciation | |||||
Non-Cash Items | -0.096 | 0 | -0.287 | 0.349 | -0.021 |
Other Non-Cash Items | |||||
Changes in Working Capital | -4.82 | -37.4 | -12.1 | 28.9 | -3.56 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 19.7 | -7.87 | -15.5 | 28 | -5.4 |
Capital Expenditures | -1.88 | -2.71 | -2.95 | -3.07 | -4.43 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.713 | -0.261 | 0.335 | -0.33 | 0.72 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.17 | -2.97 | -2.62 | -3.4 | -3.71 |
Financing Cash Flow Items | — | — | — | 0.001 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -18.4 | 12.1 | 16.6 | -21.2 | 10.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.415 | 1.48 | -1.18 | 3.11 | 1.43 |